Get started
Illumina, Inc.Illumina, Inc.Illumina, Inc.

Illumina, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

ILMN chart


Full chart

Key facts today

Illumina's CFO Ankur Dhingra revealed that 25% of revenue comes from government research, primarily NIH grants, highlighting potential impacts on the company if NIH funding decreases.
Analyze the impactAnalyze the impact

ILMN upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪21.41 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−9.97 USD
Net income (FY)
‪−1.16 B‬ USD
Revenue (FY)
‪4.50 B‬ USD
Shares float
‪157.81 M‬
Beta (1Y)
1.38

Employees


Employees (FY)
‪12.01 K‬
Change (1Y)
+510 +4.43%
Revenue / Employee (1Y)
‪375.02 K‬ USD
Net income / Employee (1Y)
‪−96.67 K‬ USD

About Illumina, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Jacob Thaysen
Website
illumina.com
Headquarters
San Diego
Founded
1998
FIGI
BBG000DSMS70
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

ILMN news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ILMN highest yielding bonds


ILMN5150650
Illumina, Inc. 2.55% 23-MAR-2031
Yield to maturity
5.31%
Maturity date
Mar 23, 2031
ILMN5508412
Illumina, Inc. 5.75% 13-DEC-2027
Yield to maturity
4.98%
Maturity date
Dec 13, 2027
ILMN5886317
Illumina, Inc. 4.65% 09-SEP-2026
Yield to maturity
4.98%
Maturity date
Sep 9, 2026
ILMN5508411
Illumina, Inc. 5.8% 12-DEC-2025
Yield to maturity
4.93%
Maturity date
Dec 12, 2025

Explore more bonds 

Sparks


Curated watchlists where ILMN is featured.

See all sparks 

Frequently Asked Questions


The current price of ILMN is 131.68 USD — it has decreased by −2.57% in the past 24 hours. Watch Illumina, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Illumina, Inc. stocks are traded under the ticker ILMN.
ILMN stock has fallen by −10.95% compared to the previous week, the month change is a −9.08% fall, over the last year Illumina, Inc. has showed a 38.66% increase.
We've gathered analysts' opinions on Illumina, Inc. future price: according to them, ILMN price has a max estimate of 254.00 USD and a min estimate of 120.00 USD. Watch ILMN chart and read a more detailed Illumina, Inc. stock forecast: see what analysts think of Illumina, Inc. and suggest that you do with its stocks.
ILMN reached its all-time high on Feb 12, 2021 with the price of 540.12 USD, and its all-time low was 0.83 USD and was reached on Mar 13, 2003. View more price dynamics on ILMN chart.
See other stocks reaching their highest and lowest prices.
ILMN stock is 4.07% volatile and has beta coefficient of 1.38. Track Illumina, Inc. stock price on the chart and check out the list of the most volatile stocks — is Illumina, Inc. there?
Today Illumina, Inc. has the market capitalization of ‪21.41 B‬, it has decreased by −2.77% over the last week.
Yes, you can track Illumina, Inc. financials in yearly and quarterly reports right on TradingView.
Illumina, Inc. is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
ILMN earnings for the last quarter are 1.14 USD per share, whereas the estimation was 0.88 USD resulting in a 29.74% surprise. The estimated earnings for the next quarter are 0.92 USD per share. See more details about Illumina, Inc. earnings.
Illumina, Inc. revenue for the last quarter amounts to ‪1.08 B‬ USD, despite the estimated figure of ‪1.08 B‬ USD. In the next quarter, revenue is expected to reach ‪1.07 B‬ USD.
ILMN net income for the last quarter is ‪705.00 M‬ USD, while the quarter before that showed ‪−1.99 B‬ USD of net income which accounts for 135.46% change. Track more Illumina, Inc. financial stats to get the full picture.
No, ILMN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has ‪12.01 K‬ employees. See our rating of the largest employees — is Illumina, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Illumina, Inc. EBITDA is ‪1.36 B‬ USD, and current EBITDA margin is 7.50%. See more stats in Illumina, Inc. financial statements.
Like other stocks, ILMN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Illumina, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Illumina, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Illumina, Inc. stock shows the sell signal. See more of Illumina, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.